Deal Snapshot
Polpharma Biologics Integrates Dutch Based Subsidiary Acquired in 2016
Wednesday 15 July 2020

In 2016, Poland-based biopharmaceutical company Polpharma Biologics acquired Dutch-based Bioceros and their proprietary cell line development platform CHOBC, as well as their discovery, process development and analytical capabilities.

Polpharma Biologics is now taking a further step and integrating Bioceros' Utrecht site and their advanced cell line development capabilities fully into an already extensive biologics development and manufacturing offering, and retiring the Bioceros name.

Date Published: 15/07/2020